Metabolomic analysis of bacterial infection markers in blood samples of patients with decompensated liver cirrhosis infused with the novel drug VS-01

MLA

Frank Uschner, et al. “Metabolomic Analysis of Bacterial Infection Markers in Blood Samples of Patients with Decompensated Liver Cirrhosis Infused with the Novel Drug VS-01.” Journal of Hepatology, vol. 77, July 2022, p. S354. EBSCOhost, https://doi.org/10.1016/s0168-8278(22)01064-9.

APA

Frank Uschner, Olaf Tyc, Wenyi Gu, Martin Schulz, Philip Ferstl, Katharina Staufer, Philipp Stoffers, Hans-Peter Erasmus, Johannes Masseli, Kai-Henrik Peiffer, Fabian Finkelmeier, Anita Pathil-Warth, Jörg Bojunga, Stefan Zeuzem, Meriam Kabbaj, & Jonel Trebicka. (2022). Metabolomic analysis of bacterial infection markers in blood samples of patients with decompensated liver cirrhosis infused with the novel drug VS-01. Journal of Hepatology, 77, S354. https://doi.org/10.1016/s0168-8278(22)01064-9

Chicago

Frank Uschner, Olaf Tyc, Wenyi Gu, Martin Schulz, Philip Ferstl, Katharina Staufer, Philipp Stoffers, et al. 2022. “Metabolomic Analysis of Bacterial Infection Markers in Blood Samples of Patients with Decompensated Liver Cirrhosis Infused with the Novel Drug VS-01.” Journal of Hepatology 77 (July): S354. doi:10.1016/s0168-8278(22)01064-9.